Article Topic
Prescription Drug Affordability Board Activity, December 2025
Prescription Drug Affordability Board Activity, December 2025 Activities Summary Colorado: In October, Colorado’s PDAB heard testimony about its decision to set an upper payment limit on Enbrel, and set price of $600 per 50mg/1ml, effective January 1, 2027. The board’s next meeting is January 9, 2026. Maryland:The PDAB met on December 8, 2025 to review…
[...]PSM endorses Iowa HSB 591 to strengthen med spa oversight for Iowans
The bill will protect Iowa’s patients by closing enormous regulatory gaps in the med spa and wellness industry.
[...]In July, Google promised to rid their platform of criminals selling pill presses. How’s it going?
As of the first week of January, we found several companies with multiple ads still running well past its self-imposed deadline. Google can do better, but will they?
[...]FDA Alert: Supplements with undeclared drug ingredients
The FDA has posted notices for two nationwide dietary supplement recalls involving products found to contain undeclared pharmaceutical ingredients.
[...]Prescription Drug Affordability Board Activity, November 2025
Prescription Drug Affordability Board Activity, November 2025 Activities Summary Colorado: In October, Colorado’s PDAB heard testimony about its decision to set an upper payment limit on Enbrel, and set price of $600 per 50mg/1ml, effective January 1, 2027. The board’s next meeting is January 9, 2026. Maryland:The PDAB met on November 17, 2025 where they…
[...]Intelligence Alert: Unlicensed med spas are selling unregulated diabetes and weight loss injectables that threaten public safety
Based on recent investigative reporting by the Partnership for Safe Medicines (PSM), patients in your state may be receiving weight loss injectables from unlicensed sources that do not meet FDA requirements for safety and sterility. PSM has established a dedicated contact from CBP/HSI to support investigations by state law enforcement on this issue.
[...]December 15, 2025: A Massachusetts man will plead to giving botulism-causing injections, says the U.S. Attorney’s Office
The med spa owner admitted to using unapproved injectables that sickened at least 10 patients. New York authorities announced the results of a 2024 crackdown on illegal med spas. PSM published in The Journal of Illicit Trade, Financial Crime, and Compliance.
[...]PSM urges the House Energy & Commerce Committee to support the SAFE Drugs Act of 2025
PSM wrote the House Energy & Commerce Committee in support of the Safeguarding Americans from Fraudulent and Experimental (SAFE) Drugs Act, to help protect the American drug supply from unsafely compounded medication.
[...]FDA Alert: More Counterfeit Ozempic found in U.S. Supply Chain
The FDA and Novo Nordisk are warning the public about counterfeit Ozempic injections circulating in the legitimate U.S. drug supply chain. The FDA announced the seizure of multiple batches of counterfeit Ozempic 1 mg injections, labeled with lot number PAR1229, on December 5, 2025. Their contents and safety are unverified and pose serious health risks.
[...]Prescription Drug Affordability Board Activity, October 2025
Prescription Drug Affordability Board Activity, October 2025 Activities Summary Colorado: Colorado’s PDAB heard testimony about its decision to set an upper payment limit on Enbrel, and set price of $600 per 50mg/1ml, effective January 1, 2027. The board’s next meeting was rescheduled from November 14, 2025 to January 9, 2026. Maryland: The PDAB will next…
[...]